These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1557821)

  • 21. [Neuroendocrine carcinoma (Merkel's cell tumor) of the skin].
    Hübner G; Remberger K; Pielsticker K
    Pathologe; 1983 Jul; 4(4):212-8. PubMed ID: 6889293
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombomodulin staining of mesothelioma cells.
    Collins CL; Fink LM; Hsu SM; Schaefer R; Ordonez N
    Hum Pathol; 1992 Aug; 23(8):966. PubMed ID: 1322862
    [No Abstract]   [Full Text] [Related]  

  • 23. [Expression of mesothelin as a potential diagnostic marker in mesothelioma].
    Kuribayashi K; Fukuoka K; Nakajima T; Miyake M; Miyata S; Tamura K; Iida S; Yamada S; Murakami A; Hirano H; Nakano T
    Nihon Kokyuki Gakkai Zasshi; 2008 Jan; 46(1):3-9. PubMed ID: 18260303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of malignant mesothelioma by fine needle aspiration of a cervical lymph node. A case report.
    Ansari NA; Derias NW
    Acta Cytol; 2000; 44(1):70-4. PubMed ID: 10667164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrastructural features of diffuse malignant mesotheliomas.
    Oury TD; Hammar SP; Roggli VL
    Hum Pathol; 1998 Dec; 29(12):1382-92. PubMed ID: 9865823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [BRCA1 associated protein 1 (BAP1) expression in pleural diffuse malignant mesothelioma: A comparative cytological and histological analyses on 50 patients].
    Jaouen A; Thivolet-Bejui F; Chalabreysse L; Piaton E; Traverse-Glehen A; Isaac S; Decaussin-Petrucci M; Depaepe L; Fontaine J; Remy I; Maury JM; Brevet M
    Ann Pathol; 2016 Apr; 36(2):111-9. PubMed ID: 26995100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions.
    Delahaye M; van der Ham F; van der Kwast TH
    Diagn Cytopathol; 1997 Aug; 17(2):115-20. PubMed ID: 9258618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In search of a positive immunohistochemical marker for mesothelioma: an update.
    Ordóñez NG
    Adv Anat Pathol; 1998 Jan; 5(1):53-60. PubMed ID: 9868512
    [No Abstract]   [Full Text] [Related]  

  • 29. Ultrastructural studies of cells in body cavity effusions.
    Bewtra C; Greer KP
    Acta Cytol; 1985; 29(3):226-38. PubMed ID: 3859122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stromal elements for tumor diagnosis: a brief review of diagnostic electron microscopic features.
    Min KW
    Ultrastruct Pathol; 2005; 29(3-4):305-18. PubMed ID: 16036885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis.
    Carella R; Deleonardi G; D'Errico A; Salerno A; Egarter-Vigl E; Seebacher C; Donazzan G; Grigioni WF
    Am J Surg Pathol; 2001 Jan; 25(1):43-50. PubMed ID: 11145250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electron microscopy of Merkel cell carcinoma from formalin-fixed tissue.
    Haneke E
    J Am Acad Dermatol; 1985 Mar; 12(3):487-92. PubMed ID: 3886719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calretinin: a novel immunocytochemical marker for mesothelioma.
    Doglioni C; Dei Tos AP; Laurino L; Iuzzolino P; Chiarelli C; Celio MR; Viale G
    Am J Surg Pathol; 1996 Sep; 20(9):1037-46. PubMed ID: 8764740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electron microscopy in tumor diagnosis: indications for its use in the immunohistochemical era.
    Ordóñez NG; Mackay B
    Hum Pathol; 1998 Dec; 29(12):1403-11. PubMed ID: 9865825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. h-Caldesmon, a useful positive marker in the diagnosis of pleural malignant mesothelioma, epithelioid type.
    Comin CE; Dini S; Novelli L; Santi R; Asirelli G; Messerini L
    Am J Surg Pathol; 2006 Apr; 30(4):463-9. PubMed ID: 16625092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of E-cadherin and N-cadherin immunostaining in the diagnosis of mesothelioma.
    Ordóñez NG
    Hum Pathol; 2003 Aug; 34(8):749-55. PubMed ID: 14506634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions.
    Chhieng DC; Yee H; Schaefer D; Cangiarella JF; Jagirdar J; Chiriboga LA; Jagirdar J; Chiriboga LA; Cohen JM
    Cancer; 2000 Jun; 90(3):194-200. PubMed ID: 10896333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical localization of prekeratin filaments in benign and malignant cells in effusions. Comparison with intermediate filament distribution by electron microscopy.
    Kahn HJ; Hanna W; Yeger H; Baumal R
    Am J Pathol; 1982 Nov; 109(2):206-14. PubMed ID: 6182803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing role of immunopathology in diagnosis of malignant mesothelioma.
    Sheibani K
    Hum Pathol; 1997 Jun; 28(6):639-40. PubMed ID: 9190995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.